{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:28:38Z","timestamp":1776871718024,"version":"3.51.2"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Mathematical modeling has provided important insights into HIV infection dynamics in adults undergoing antiretroviral treatment (ART). However, much less is known about the corresponding dynamics in perinatally infected neonates initiating early ART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting:<\/jats:title><jats:p>From 2014 to 2017, HIV viral load (VL) was monitored in 122 perinatally infected infants identified at birth and initiating ART within a median of 2 days. Pretreatment infant and maternal covariates, including CD4 T cell counts and percentages, were also measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>From the initial cohort, 53 infants demonstrated consistent decline and suppressed VL below the detection threshold (20 copies mL<jats:sup>\u22121<\/jats:sup>) within 1 year. For 43 of these infants with sufficient VL data, we fit a mathematical model describing the loss of short-lived and long-lived infected cells during ART. We then estimated the lifespans of infected cells and the time to viral suppression, and tested for correlations with pretreatment covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Most parameters governing the kinetics of VL decline were consistent with those obtained previously from adults and other infants. However, our estimates of the lifespan of short-lived infected cells were longer than published values. This difference may reflect sparse sampling during the early stages of VL decline, when the loss of short-lived cells is most apparent. In addition, infants with higher pretreatment CD4 percentage or lower pretreatment VL trended toward more rapid viral suppression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>HIV dynamics in perinatally infected neonates initiating early ART are broadly similar to those observed in other age groups. Accelerated viral suppression is also associated with higher CD4 percentage and lower VL.<\/jats:p><\/jats:sec>","DOI":"10.1097\/qai.0000000000002425","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:26:43Z","timestamp":1592940403000},"page":"209-218","source":"Crossref","is-referenced-by-count":8,"title":["Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy"],"prefix":"10.1097","volume":"85","author":[{"given":"Sinead E.","family":"Morris","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luise","family":"Dziobek-Garrett","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY;"},{"name":"Office of University Investments, Cornell University, New York, NY 10032 ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Strehlau","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Schr\u00f6ter","sequence":"additional","affiliation":[{"name":"Department of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Shiau","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY;"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anet J. N.","family":"Anelone","sequence":"additional","affiliation":[{"name":"Department of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands;"},{"name":"School of Mathematics and Statistics, University of Sydney, Sydney, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Paximadis","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY;"},{"name":"ICAP at Columbia University, Mailman School of Public Health, Columbia University Medical Center, New York, NY; and"},{"name":"Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University Medical Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline T.","family":"Tiemessen","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY;"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the EPIICAL Consortium and the LEOPARD study team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230927","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet."},{"key":"R3-20230927","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.aids.0000200529.64113.3e","article-title":"Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection","volume":"20","author":"Chiappini","year":"2006","journal-title":"AIDS."},{"key":"R4-20230927","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med."},{"key":"R5-20230927","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/cid\/cir950","article-title":"Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation","volume":"54","author":"Goetghebuer","year":"2012","journal-title":"Clin Infect Dis."},{"key":"R6-20230927","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(13)61409-9","article-title":"Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial","volume":"382","author":"Cotton","year":"2013","journal-title":"Lancet."},{"key":"R7-20230927","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu297","article-title":"HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1\u2013infected children who received early treatment","volume":"210","author":"Luzuriaga","year":"2014","journal-title":"J Infect Dis."},{"key":"R8-20230927","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/cid\/civ456","article-title":"Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy","volume":"61","author":"Mart\u00ednez-Bonet","year":"2015","journal-title":"Clin Infect Dis."},{"key":"R9-20230927","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/infdis\/jiu827","article-title":"Early antiretroviral therapy in South African children reduces HIV-1-infected cells and cell-associated HIV-1 RNA in blood mononuclear cells","volume":"212","author":"van Zyl","year":"2015","journal-title":"J Infect Dis."},{"key":"R10-20230927","doi-asserted-by":"crossref","first-page":"e0154391","DOI":"10.1371\/journal.pone.0154391","article-title":"Early combination antiretroviral therapy limits exposure to HIV-1 replication and cell-associated HIV-1 DNA levels in infants","volume":"11","author":"McManus","year":"2016","journal-title":"PLoS One."},{"key":"R11-20230927","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAD.0000000000001312","article-title":"Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants","volume":"31","author":"Shiau","year":"2018","journal-title":"AIDS."},{"key":"R12-20230927","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/QAD.0000000000002172","article-title":"Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand","volume":"33","author":"Chan","year":"2019","journal-title":"AIDS."},{"key":"R13-20230927","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/17512433.2017.1398645","article-title":"The pharmacological treatment of acute HIV infections in neonates","volume":"10","author":"Kuhn","year":"2017","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R14-20230927","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet."},{"key":"R15-20230927","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature."},{"key":"R16-20230927","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature."},{"key":"R17-20230927","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.0006-341X.1999.00410.x","article-title":"Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials","volume":"55","author":"Wu","year":"1999","journal-title":"Biometrics."},{"key":"R18-20230927","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0000000000001101","article-title":"Viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of HIV-1 subtype C","volume":"73","author":"Shet","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"R19-20230927","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science."},{"key":"R21-20230927","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo","volume":"77","author":"Markowitz","year":"2003","journal-title":"J Virol."},{"key":"R22-20230927","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JVI.73.1.362-367.1999","article-title":"Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants","volume":"73","author":"Luzuriaga","year":"1999","journal-title":"J Virol."},{"key":"R23-20230927","doi-asserted-by":"crossref","first-page":"100241","DOI":"10.1016\/j.eclinm.2019.100241","article-title":"Early antiretroviral treatment of infants to attain HIV remission","volume":"18","author":"Kuhn","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R24-20230927","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/314670","article-title":"Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points","volume":"179","author":"Wu","year":"1999","journal-title":"J Infect Dis."},{"key":"R25-20230927","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/088922201750461285","article-title":"Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy","volume":"17","author":"Wu","year":"2001","journal-title":"AIDS Res Hum Retroviruses."},{"key":"R27-20230927","doi-asserted-by":"crossref","first-page":"E6917","DOI":"10.1073\/pnas.1517246112","article-title":"Temporal fate mapping reveals age-linked heterogeneity in naive T lymphocytes in mice","volume":"112","author":"Hogan","year":"2015","journal-title":"Proc Natl Acad Sci."},{"key":"R28-20230927","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-020-3389-x","article-title":"Ushr: understanding suppression of HIV in R","volume":"21","author":"Morris","year":"2020","journal-title":"BMC Bioinformatics."},{"key":"R29-20230927","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i03","article-title":"Parameter estimation in nonlinear mixed effect models using saemix, an R implementation of the SAEM algorithm","volume":"80","author":"Comets","year":"2017","journal-title":"J Stat Softw."},{"key":"R30-20230927","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol."},{"key":"R32-20230927","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0025-5564(99)00021-8","article-title":"Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics","volume":"160","author":"Ding","year":"1999","journal-title":"Math Biosci."},{"key":"R33-20230927","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e3282fbd1da","article-title":"Treatment response in acute\/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline","volume":"22","author":"Kilby","year":"2008","journal-title":"AIDS."},{"key":"R34-20230927","doi-asserted-by":"crossref","first-page":"SII1","DOI":"10.1016\/S0140-6736(99)90249-0","article-title":"Paediatric HIV-1 infection","volume":"354","author":"Burns","year":"1999","journal-title":"Lancet."},{"key":"R35-20230927","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med."},{"key":"R36-20230927","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa1113249","article-title":"Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children","volume":"366","author":"Violari","year":"2012","journal-title":"N Engl J Med."},{"key":"R37-20230927","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-199812000-00010","article-title":"Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen","volume":"12","author":"Notermans","year":"1998","journal-title":"AIDS."},{"key":"R38-20230927","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/QAI.0000000000002291","article-title":"Time to viral suppression in perinatally HIV-infected infants depends on the viral load and CD4 T-cell percentage at the start of treatment","volume":"83","author":"Schr\u00f6ter","year":"2020","journal-title":"J Acquir Immune Defic Syndr."},{"key":"R39-20230927","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0019006","article-title":"HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy","volume":"6","author":"van Dijk","year":"2011","journal-title":"PLoS One."},{"key":"R40-20230927","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/QAI.0000000000001499","article-title":"HIV viral load suppression in adults and children receiving antiretroviral therapy\u2014results from the IeDEA collaboration","volume":"76","author":"Jiamsakul","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"R41-20230927","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med."},{"key":"R42-20230927","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet."},{"key":"R43-20230927","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/aid.2015.0296","article-title":"Younger age predicts failure to achieve viral suppression and virologic rebound among HIV-1-infected persons in serodiscordant partnerships","volume":"32","author":"Mujugira","year":"2016","journal-title":"AIDS Res Hum Retroviruses."},{"key":"R44-20230927","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e32830437df","article-title":"Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants","volume":"22","author":"Prendergast","year":"2008","journal-title":"AIDS."},{"key":"R45-20230927","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/QAD.0000000000001125","article-title":"Predicting virological decay in patients starting combination antiretroviral therapy","volume":"30","author":"Hughes","year":"2016","journal-title":"AIDS."},{"key":"R46-20230927","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tim.2003.09.002","article-title":"Glancing behind virus load variation in HIV-1 infection","volume":"11","author":"Bonhoeffer","year":"2003","journal-title":"Trends Microbiol."},{"key":"R47-20230927","doi-asserted-by":"crossref","first-page":"e25368","DOI":"10.1002\/jia2.25368","article-title":"HIV-1 DNA decay is faster in children who initiate ART shortly after birth than later","volume":"22","author":"Veldsman","year":"2019","journal-title":"J Int AIDS Soc."},{"key":"R48-20230927","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis","volume":"354","author":"Ramratnam","year":"1999","journal-title":"Lancet."},{"key":"R49-20230927","first-page":"1","article-title":"Safety and efficacy of starting antiretroviral therapy in the first week of life","volume":"ciaa028","author":"Maswabi","year":"2020","journal-title":"Clin Infect Dis."}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000002425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:40:28Z","timestamp":1723102828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000002425","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}